SCHEMBL26324813

SCHEMBL26324813

CCOC(=O)C(CC)(Nc1ccccc1)Nc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.55
GAA P10253 3/20 0.50
PIN1 Q13526 1/20 0.49
ALDH1A1 P00352 3/20 0.47
RECQL P46063 1/20 0.47
MMP8 P22894 1/20 0.47
TDP1 Q9NUW8 1/20 0.44
LMNA P02545 1/20 0.44
MAPK1 P28482 1/20 0.44
HSD17B10 Q99714 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.43
POLB P06746 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
HPGD P15428 1/20 0.42
CRHBP P24387 1/20 0.42
CRHR2 Q13324 1/20 0.42
TSHR P16473 2/20 0.42
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2986775 0.81 MAPT (0.56) MAPTGAAPIN1ALDH1A1RECQL
SCHEMBL10980611 0.81 MAPT (0.52) MAPTGAAPIN1ALDH1A1RECQL
SCHEMBL22501165 0.80 MAPT (0.42) MAPTGAAALDH1A1HSD17B10SMN1; SMN2
SCHEMBL31306345 0.76 MAPT (0.51) MAPTGAAPIN1ALDH1A1RECQL
SCHEMBL9290181 0.74 MAPT (0.49) MAPTGAAPIN1ALDH1A1RECQL
SCHEMBL8483586 0.74 PIN1 (0.53) MAPTPIN1ALDH1A1RECQLMMP8
Ammonia Solution, Strong SCHEMBL10879989 0.72 PIN1 (0.51) MAPTPIN1ALDH1A1RECQLMMP8
SCHEMBL840864 0.72 MAPT (0.53) MAPTGAAPIN1ALDH1A1MMP8
SCHEMBL3161141 0.71 POLB (0.47) MAPTGAAPIN1ALDH1A1RECQL
SCHEMBL3103941 0.71 MAPT (0.53) MAPTGAAPIN1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents WILLIAM MARSH RICE UNIVERSITY (US) 2023-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents PNMT, NCL, NPM1 MAPT 1551/4885GAA 3549/4885PIN1 725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.